Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of Irf1 Pre-mRNA.
Bernard A, Hibos C, Richard C, Viltard E, Chevrier S, Lemoine S, Melin J, Humblin E, Mary R, Accogli T, Chalmin F, Bruchard M, Peixoto P, Hervouet E, Apetoh L, Ghiringhelli F, Végran F, Boidot R. Bernard A, et al. Among authors: hibos c. Cancer Immunol Res. 2021 Mar;9(3):324-336. doi: 10.1158/2326-6066.CIR-19-0679. Epub 2021 Jan 8. Cancer Immunol Res. 2021. PMID: 33419764 Free article.
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects.
Mary R, Chalmin F, Accogli T, Bruchard M, Hibos C, Melin J, Truntzer C, Limagne E, Derangère V, Thibaudin M, Humblin E, Boidot R, Chevrier S, Arnould L, Richard C, Klopfenstein Q, Bernard A, Urade Y, Harker JA, Apetoh L, Ghiringhelli F, Végran F. Mary R, et al. Among authors: hibos c. Cancer Immunol Res. 2022 Jul 1;10(7):900-916. doi: 10.1158/2326-6066.CIR-21-0568. Cancer Immunol Res. 2022. PMID: 35612500
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy.
Niogret J, Berger H, Rebe C, Mary R, Ballot E, Truntzer C, Thibaudin M, Derangère V, Hibos C, Hampe L, Rageot D, Accogli T, Joubert P, Routy B, Harker J, Vegran F, Ghiringhelli F, Chalmin F. Niogret J, et al. Among authors: hibos c. J Immunother Cancer. 2021 Jun;9(6):e002157. doi: 10.1136/jitc-2020-002157. J Immunother Cancer. 2021. PMID: 34103351 Free PMC article.
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, Racoeur C, Barsac E, Chalmin F, Hibos C, Baranek T, Paget C, Ryffel B, Rébé C, Paul C, Végran F, Ghiringhelli F. Bruchard M, et al. Among authors: hibos c. Nat Immunol. 2022 Feb;23(2):262-274. doi: 10.1038/s41590-021-01120-y. Epub 2022 Jan 31. Nat Immunol. 2022. PMID: 35102345
Canonical and non-canonical functions of NLRP3.
Accogli T, Hibos C, Vegran F. Accogli T, et al. Among authors: hibos c. J Adv Res. 2023 Nov;53:137-151. doi: 10.1016/j.jare.2023.01.001. Epub 2023 Jan 4. J Adv Res. 2023. PMID: 36610670 Free PMC article. Review.